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(dengue and possibly RVF) have been reported in recent 
years in Somalia: RVF outbreaks occurred during 1997–
1998 and 2006–2007 (6,7), and a dengue outbreak occurred 
during 1992–1993 (8).
The current outbreak in Somalia could have been trig-
gered by several factors, including circulation of CHIKV 
in neighboring Kenya (references 8,9 in online Technical 
Appendix) and heavy rains that led to flooding in southern 
and central Somalia beginning in January 2016 (reference 
1 in online Technical Appendix). CHIKV has the potential 
to provoke explosive outbreaks in naive populations (9), so 
the current outbreak may greatly affect the economy and 
public health in Somalia.
Systematic studies to understand the magnitude of the 
ongoing epidemic are needed. In the meantime, local pub-
lic health stakeholders in Somalia and healthcare work-
ers worldwide caring for travelers returning from Somalia 
should be aware that CHIKV is circulating in the country. 
This report confirms the importance of travel medicine 
services in performing early diagnosis of imported arbo-
viral diseases, not only to thwart secondary transmission 
during periods of competent vector activity but also to 
help to detect or confirm virus circulation in previously 
unaffected countries.
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To the Editor: In their recent letter (1), Broderick 
et al. provided useful information about the remarkable 
declines in incidence of meningococcal disease among 
active-duty US military personnel since the early 1970s, 
when meningococcal vaccination began within that pop-
ulation. The authors reported that the incidence of me-
ningococcal disease from vaccine-covered serogroups 
was 0.183 cases/100,000 persons during 2006–2013 
among persons vaccinated with quadrivalent conjugate 
meningococcal vaccine (MCV-4), compared with 0.307 
cases/100,000 persons during 2000–2013 among persons 
vaccinated with quadrivalent polysaccharide meningo-
coccal vaccine (MPSV-4). They stated that, because these 
rates did not differ significantly, case rates were similar 
in personnel vaccinated with MCV-4 and MPSV-4. Al-
though statistically correct, this comment might mislead 
the unwary reader.
The absence of a significant difference does not nec-
essarily mean that the 2 vaccines have similar effective-
ness. The incidence rate of meningococcal disease was 
68% higher ([0.307–0.183] × 100/0.183) during the pe-
riod of MPSV-4 use than during the period of MCV-4 use. 
If the same findings arose in a study of sufficient size to 
achieve statistical significance, this difference would be 
considered of substantial clinical importance. A happy 
consequence of the long-term temporal trends in menin-
gococcal incidence and the success of these vaccines is 
that the incidence of meningococcal disease is now suf-
ficiently reduced that even the very large active-duty 
population is too small to provide the statistical power to 
declare these 2 different incidence rates as being statisti-
cally different.
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The trends reported by Broderick et al. have contin-
ued. During 2006–2014, the incidence of meningococcal 
disease caused by vaccine-covered serogroups among US 
military recipients of MCV-4 fell to 0.146 per 100,000 
person-years, whereas MPVS-4–related incidence did 
not change (M.P. Broderick, pers. comm.). Furthermore, 
through July 2016, the US military has not seen a case 
from a covered serogroup since 2011 among recipients 
of MCV-4. Even with these additional data, however, the 
difference between MCV-4 and MPSV-4 does not achieve 
statistical significance (M.P. Broderick, pers. comm.).
The author is an employee of a company that manufactures both 
conjugate and polysaccharide meningococcal vaccines.
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Correction: Vol. 22, No. 8
The name of author Natalie Witek was misspelled in Baylisascaris procyonis–Associated Meningoencephalitis 
in a Previously Healthy Adult, California, USA (C. Langelier et al.). The article has been corrected online (http://wwwnc.
cdc.gov/eid/article/22/8/15-1939_article).
Corrections: Vol. 22, No. 9
Some descriptions of tickborne transmission of bacteria were unclear in Large-Scale Survey for Tickborne 
Bacteria, Khammouan Province, Laos (A.J. Taylor al.). The article has been corrected online (http://wwwnc.cdc.gov/eid/
article/22/9/15-1969_article).
A second affiliation for author Martie L. van der Walt was omitted in Treatment Outcomes for Patients with 
Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa (C.L. Kvasnovsky 
et al.). The article has been corrected online (http://wwwnc.cdc.gov/eid/article/22/9/16-0084_article).
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EID Podcast: Nipah Virus Transmission from  
Bats to Humans Associated with Drinking  
Traditional Liquor Made from Date Palm Sap,  
Bangladesh, 2011–2014
Nipah virus (NiV) is a paramyxovirus, and Pteropus spp. bats are the natural reservoir. 
From December 2010 through March 2014, hospital-based encephalitis surveillance 
in Bangladesh identified 18 clusters of NiV infection. A team of 
epidemiologists and anthropologists investigated and found that 
among the 14 case-patients, 8 drank fermented date palm 
sap (tari) regularly before their illness, and 6 provided care 
to a person infected with NiV. The process of preparing date 
palm trees for tari production was similar to the process of 
collecting date palm sap for fresh consumption. Bat excreta 
was reportedly found inside pots used to make tari. These 
findings suggest that drinking tari is a potential pathway of 
NiV transmission.
